Treatment of Diabetic Foot Ulcer (DFU)

1. Glycemic Control and Systemic Optimization

2. Vascular Assessment (First, Before Aggressive Debridement)

• Palpate dorsalis pedis and posterior tibial pulses
• Ankle-brachial index (ABI): unreliable in diabetics due to arterial calcification (non-compressible vessels)
• Toe-brachial index (TBI): preferred; >0.4 or absolute toe pressure >40 mmHg = adequate perfusion for healing
• If perfusion is inadequate, refer to a vascular surgeon for revascularization before wound debridement

3. Wound Classification (Wagner System)

4. Offloading

• Total contact cast (TCC): gold standard for plantar DFUs - redistributes plantar pressure across the entire leg and foot
• Removable cast walker (RCW): practical but less effective if the patient removes it
• Felted foam padding, custom therapeutic footwear, or surgical offloading (correction of Charcot deformity, metatarsal head resection) for pressure redistribution
• Patients must be educated that continued ambulation on an unprotected ulcer is the primary cause of healing failure

5. Debridement

6. Infection Management

1. Patient level - glucose control, immune status
2. Limb level - neuropathy, PAD
3. Wound level - depth, infection signs, osteomyelitis

• Positive probe-to-bone test (metallic "click" on probing) is highly suggestive
• MRI is the most sensitive imaging modality to confirm or exclude osteomyelitis
• Bone biopsy remains the gold standard for culture-guided antibiotic therapy

• Mild-moderate infections: oral antibiotics active against gram-positive cocci (MRSA coverage if risk factors present - e.g., TMP-SMX, doxycycline, or linezolid)
• Severe infections: IV antibiotics, empiric broad-spectrum coverage (gram-positives + gram-negatives + anaerobes), guided by deep tissue cultures (NOT surface swabs, which have poor predictive value)
• Severe infections: hospitalize, consult surgery, follow IDSA guidelines
• Osteomyelitis: 4-6 weeks of antibiotic therapy; surgical resection of infected bone often required - Textbook of Family Medicine 9e, p. 266

7. Wound Dressings and Local Wound Care

8. Advanced Wound Therapies

• Negative Pressure Wound Therapy (NPWT): promotes granulation, removes exudate, reduces edema; commonly used post-debridement or post-amputation
• Platelet-Rich Plasma (PRP): autologous growth factors accelerate healing; a 2024 meta-analysis (PMID 38278034) supports APRP in diabetic foot disease
• Bioengineered skin substitutes (e.g., Apligraf, Dermagraft): bilayer living constructs; used for non-infected, adequately perfused wounds
• Hyperbaric Oxygen Therapy (HBO): increases tissue oxygen delivery; indicated in wounds with tissue hypoxia; adjunct, not standalone
• Photodynamic therapy (PDT): a 2024 systematic review and meta-analysis (PMID 38866070) supports PDT as an effective adjunctive therapy for DFUs
• Growth factors (e.g., becaplermin/PDGF): topical application; modest benefit for neuropathic ulcers
• A 2025 network meta-analysis comparing 12 interventions for DFUs (PMID 40821981) provides current comparative efficacy data

9. Surgical Management

• Incision and drainage (I&D): for abscess or deep space infections
• Debridement + secondary closure: for infected wounds without significant tissue loss
• Skin grafting or flap reconstruction: for large, clean, granulating wounds
• Ray amputation: removal of a toe and portion of its metatarsal for localized gangrene
• Below-knee (BKA) or above-knee amputation (AKA): for unsalvageable limbs; mortality is high in the perioperative period due to systemic comorbidities

10. Multidisciplinary Team Approach

• Endocrinologist/primary care: glycemic control
• Vascular surgeon: revascularization
• Orthopedic/podiatric surgeon: debridement, offloading, deformity correction
• Infectious disease: complex antibiotic regimens
• Wound care nurse: ongoing dressing management
• Orthotist: custom footwear
• Diabetic educator and patient: adherence and prevention

Prevention (Equally Important)

• Daily foot inspection
• Proper footwear (no bare feet, no tight shoes)
• Routine podiatric nail and callus care
• Semmes-Weinstein monofilament testing annually to detect neuropathy early
• Aggressive control of modifiable risk factors (smoking cessation, blood pressure, lipids)

• Fischer's Mastery of Surgery, 8th Ed., Chapter on Diabetic Foot Wound Management
• Textbook of Family Medicine, 9th Ed., p. 266 - Diabetic Foot Ulcer Infections
• PMID 38278034 - PRP meta-analysis (2024)
• PMID 38866070 - Photodynamic therapy meta-analysis (2024)
• PMID 40821981 - Network meta-analysis of 12 DFU interventions (2025)
• PMID 41637846 - Comprehensive DFU review (2026)

RBS of 4000 mg/dL - This is a Medical Emergency

Normal plasma glucose: 70-140 mg/dL. HHS is defined as glucose >600 mg/dL; values of 1000-4000 mg/dL indicate extreme HHS.

Step 1: Immediate Assessment (within minutes)

• Serum glucose (confirm), electrolytes, BUN, creatinine
• Serum osmolality (calculated: 2[Na] + glucose/18 + BUN/2.8)
• ABG (assess pH, CO2)
• Serum/urine ketones
• CBC, LFTs, urinalysis
• ECG (look for hypokalemia changes)
• Blood cultures, CXR if sepsis suspected
• Corrected sodium: add 1.6 mEq to measured Na for every 100 mg/dL rise in glucose above 100

Step 2: IV Fluid Resuscitation (MOST CRITICAL STEP)

• 0.9% Normal Saline (NS): 1-3 L over the first 2-3 hours
• If hypotensive/shocked: 1 L boluses rapidly until BP stabilizes
• Children: 20 mL/kg NS in first hour

• If corrected Na >150 mEq/L: use 0.45% half-normal saline at 150-500 mL/h
• If hyponatremic: continue 0.9% NS at 150-500 mL/h
• Rate adjustment: aim for no faster than 3 mOsm/kg/h decrease in osmolality to avoid cerebral edema
• Target positive fluid balance over 12-24 hours
• Avoid correcting glucose faster than 50-75 mg/dL per hour (max 100 mg/dL/h) - rapid correction risks osmotic encephalopathy

Step 3: Insulin Therapy

Critical rule: Do NOT start insulin until potassium is ≥3.3 mEq/L - insulin drives K+ into cells and can cause fatal hypokalemia.

• IV Regular insulin: 0.1 units/kg bolus, then 0.1 units/kg/h infusion
• Preparation: 100 units regular insulin in 100 mL 0.9% NS (1 unit/mL) at 10 mL/h = 10 units/h
• Target glucose fall: 50-75 mg/dL/h
• When glucose reaches 250-300 mg/dL: add D5W to IV fluids to prevent hypoglycemia, reduce insulin to 0.05 units/kg/h
• Continue insulin infusion until osmolality <315 mOsm/L, patient mentally alert, and able to eat
• Before stopping insulin infusion: give subcutaneous basal insulin 2 hours prior to prevent rebound hyperglycemia

Step 4: Electrolyte Replacement

• Despite total body K+ depletion, serum K+ may appear normal or high initially (insulin + acidosis correction will drive it down sharply)
• If K+ 3.3-5.5 mEq/L: add 20-40 mEq KCl per liter of IV fluid
• If K+ <3.3 mEq/L: hold insulin, replace aggressively (40 mEq/h) until ≥3.3, then restart insulin
• If K+ >5.5 mEq/L: hold potassium supplementation, monitor every 2 hours

• Usually not necessary to replace unless severely low or symptomatic

• If low: 1-2 g MgSO4 IV

• Consider only if pH <6.9; routine bicarbonate use is NOT recommended - IV fluids and insulin will correct the acidosis

Step 5: Identify and Treat the Precipitating Cause

• Infection (pneumonia, UTI, sepsis) - most common trigger
• Myocardial infarction (get ECG)
• Stroke (get CT head if focal neuro signs)
• Medication non-compliance or first presentation of undiagnosed DM
• Medications (steroids, thiazides, antipsychotics)
• Inadequate fluid intake (elderly, bedridden, dementia)

Step 6: Monitoring (ICU Level)

• Serum glucose every 1 hour until stable
• Electrolytes (Na, K, Cl, HCO3) every 2-4 hours
• Urine output (target >0.5 mL/kg/h)
• Vital signs every 15-30 minutes initially
• Osmolality every 4-6 hours
• Neurological status (HHS glucose >1000 is associated with coma)

Prognosis Warning

HHS carries a mortality rate up to 15% even with proper treatment, compared to <1% for DKA. Mortality reflects the severity of the precipitating illness and comorbidities, not just the hyperglycemia itself. - Harrison's Principles of Internal Medicine 22E, p. 3262

Summary Algorithm

RBS 4000 mg/dL
     ↓
IMMEDIATE: ABC, IV access x2, ECG, labs (glucose, lytes, BUN/Cr, ketones, ABG, CBC)
     ↓
0.9% NS 1-3 L/h (hemodynamic stabilization) → Check K+
     ↓
K+ ≥ 3.3 → Start insulin 0.1 U/kg bolus + 0.1 U/kg/h infusion
     ↓
Glucose 250-300 → Switch to D5W + reduce insulin to 0.05 U/kg/h
     ↓
Replace K+, Mg2+, Phos as needed
     ↓
Find and treat precipitant
     ↓
ICU monitoring until osmolality normalized, patient awake, tolerating orals

• Harrison's Principles of Internal Medicine 22E (2025), p. 3262 - HHS treatment
• The Washington Manual of Medical Therapeutics, p. 890 - DKA treatment table
• Rosen's Emergency Medicine, Box 115.1 - DKA treatment summary

RBS of 400 mg/dL - Assessment and Treatment

Step 1: Assess the Patient - Is This an Emergency?

Critical rule: Any RBS ≥300 mg/dL should prompt immediate testing for ketones and electrolytes to rule out DKA. - Washington Manual of Medical Therapeutics, p. 888

Step 2: Check Urgently

• Urine/blood ketones (if positive + pH <7.3 + HCO3 <15 = DKA - manage as emergency)
• Serum electrolytes (especially potassium - critical before insulin)
• Renal function (BUN/creatinine)
• HbA1c (to assess chronicity of poor control)
• Urinalysis, CBC if infection suspected
• Vital signs - BP, HR, hydration status

Step 3: Treatment Based on Scenario

Scenario A: Symptomatic / Ketones Present / Acidosis → Hospital/Emergency

1. IV 0.9% Normal Saline 1 L bolus
2. Check K+ - do NOT give insulin until K+ ≥3.3 mEq/L
3. IV regular insulin 0.1 units/kg bolus + 0.1 units/kg/h infusion
4. Replace electrolytes, identify precipitant
5. Monitor hourly glucose, electrolytes every 2-4 hours

Scenario B: Asymptomatic, Hospitalized Patient (Non-ICU)

• 400 - 140 = 260 mg/dL above target
• 260 ÷ 50 = 5.2 → give 5-10 units correction insulin (on top of scheduled dose)

Scenario C: Outpatient / Known T2DM, Asymptomatic

1. Hydration - drink plenty of water (helps kidneys excrete excess glucose via osmotic diuresis)
2. Avoid high-carbohydrate foods and sugary drinks immediately
3. Physical activity (if no contraindications) - a 20-30 minute walk can lower glucose by 30-50 mg/dL

• Metformin: 500-1000 mg BD (first-line, lowers glucose ~1-2 mmol/L)
• SGLT-2 inhibitors (empagliflozin, dapagliflozin): glucose-lowering + cardioprotective
• GLP-1 agonists (semaglutide, liraglutide): glucose-lowering + weight loss
• Basal insulin (glargine/detemir): most effective for very high glucose like 400 mg/dL

• Glucose not coming down with oral fluids and medications
• Symptoms develop (vomiting, confusion, chest pain)
• Ketones positive
• Cannot tolerate oral fluids

Scenario D: Type 1 DM

• Always check ketones - T1DM develops ketoacidosis within 12-24 hours without insulin
• If ketone negative: give correction dose of rapid-acting insulin (1 unit per 50 mg/dL above target, often 1:50 correction ratio), recheck in 1-2 hours
• If ketone positive: treat as DKA, hospital admission
• The insulin requirement for T1DM is 0.5-0.8 units/kg/day total (40-50% as basal, remainder as bolus + correction) - Washington Manual of Medical Therapeutics, p. 895

Step 4: Blood Glucose Targets

Step 5: Address the Cause

• Missed insulin or medication doses
• Dietary indiscretion (large carbohydrate meal)
• Infection or illness (stress hyperglycemia)
• Steroid use
• New diagnosis of diabetes (unaware)

Summary Decision Tree

RBS = 400 mg/dL
        ↓
Any symptoms? (vomiting, pain, confusion, rapid breathing)
   YES → Check ketones + ABG → If DKA/HHS → Hospital/ICU
   NO  ↓
Check ketones
   Positive → Hospital, treat DKA
   Negative ↓
T1DM → Correction dose rapid insulin, recheck 1-2h
T2DM (hospitalized) → Basal-bolus-correction regimen
T2DM (outpatient) → Hydrate, adjust oral/injectable meds, recheck in 2-4h, follow up same day
        ↓
Identify and treat precipitating cause
        ↓
Adjust long-term regimen to prevent recurrence

• The Washington Manual of Medical Therapeutics, pp. 887-895 - Hyperglycemia management, T1DM treatment
• Rosen's Emergency Medicine - DKA treatment summary
• Harrison's Principles of Internal Medicine 22E (2025) - HHS/DKA pathophysiology and management

Glimepiride in Diabetic Patients - Complete Prescribing Guide

Drug Class and Mechanism

• Binding to the SUR1 receptor on pancreatic beta-cell K-ATP channels
• Inhibiting the K-ATP channel → membrane depolarization → calcium influx → insulin secretion
• It achieves blood glucose lowering at the lowest dosage of any sulfonylurea
• It is used for type 2 diabetes only (requires functional beta cells)

Dosing

A single daily dose of 1 mg has been shown to be effective - always start low and titrate. - Katzung's Basic and Clinical Pharmacology 16e, p. 1185

How to Give (Administration)

• Timing: Take with breakfast or the first main meal of the day - taking with food reduces GI side effects and risk of early hypoglycemia
• Route: Oral only
• Frequency: Once daily (the 24-hour duration allows single daily dosing, which aids compliance)
• Titration: Increase by 1-2 mg every 1-2 weeks based on fasting blood glucose response
• Swallow whole with water; do not crush or chew

Titration Schedule

Week 1-2:     1 mg once daily with breakfast
Week 3-4:     2 mg once daily (if FBS still >130 mg/dL)
Week 5-6:     3-4 mg once daily (if inadequate control)
Maximum:      8 mg once daily

Indications

• Type 2 diabetes mellitus - as monotherapy or in combination with:
  • Metformin
  • SGLT-2 inhibitors
  • DPP-4 inhibitors
  • Insulin (combination use - reduce insulin dose to avoid hypoglycemia)
• Responds well in 50-80% of appropriately selected patients

Contraindications

Special Populations

Side Effects

• Most serious and common adverse effect
• Risk is higher if: meal is skipped, excess exercise, alcohol use, renal/hepatic impairment, drug interactions
• Symptoms: sweating, tremors, palpitations, confusion, loss of consciousness
• Treat mild hypoglycemia with 15g fast-acting carbohydrate (glucose tablets, juice)
• Treat severe hypoglycemia with IV dextrose (25-50 mL of D50W) or IM glucagon

• Weight gain of 1-3 kg (class effect of all sulfonylureas)
• Nausea, GI upset (take with food to minimize)
• Rare: photosensitivity, skin rash, leukopenia, agranulocytosis (class effect)

Drug Interactions

Monitoring

• Fasting blood glucose: weekly during titration, then every 3 months
• HbA1c: every 3 months until target achieved, then every 6 months
• Renal function (eGFR/creatinine): at least annually
• Liver function: annually
• Body weight: at each visit
• Hypoglycemia episodes: patient to keep log

Patient Counseling Points

1. Take with your first meal every day - do not skip meals after taking the tablet
2. Keep a glucose source (sugar, juice, glucose tablets) available at all times
3. Do not skip meals - this is the most common cause of hypoglycemia with glimepiride
4. Alcohol can cause unpredictable blood sugar changes - limit intake
5. Report any signs of hypoglycemia immediately
6. The drug does not work in type 1 diabetes - insulin is needed there
7. Regular glucose monitoring and HbA1c checks are essential
8. Weight gain is expected - continue dietary discipline

Comparison with Other Sulfonylureas

• Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 1054 - Sulfonylurea properties table (Glimepiride 1-8 mg, 24h duration)
• Katzung's Basic and Clinical Pharmacology 16e, p. 1185 - Glimepiride once-daily dosing, max 8 mg, half-life 5-9h

Prazosin for Scorpion Envenomation in Adults

Why Prazosin?

• Severe hypertension, tachycardia
• Pulmonary edema (the main cause of death)
• Cold clammy extremities, profuse sweating
• Priapism, excessive salivation

Adult Dose of Prazosin

For adults >20 kg body weight: 1 mg every 3 hours is the standard clinical dose used in trials from Maharashtra, India (Bawaskar protocol). - PMC5385045 systematic review

When to Give Prazosin

• Profuse sweating
• Cold extremities / peripheral vasoconstriction
• Hypertension + tachycardia (sympathetic predominance)
• Priapism
• Pulmonary edema
• Hypertension and pulmonary edema respond to prazosin (alongside nifedipine, nitroprusside, or hydralazine as alternatives) - Harrison's Principles of Internal Medicine 22E

• Only local pain at sting site (no systemic features) - treat with analgesics/ice only
• Patient is hypotensive - prazosin will worsen hypotension
• Parasympathetic storm is predominant (bradycardia, excessive secretions from certain species) - use atropine instead

Bawaskar Protocol (India - Most Widely Used)

Step 1: On arrival with autonomic storm →
        Prazosin 30 mcg/kg oral IMMEDIATELY
        (= ~500 mcg to 1 mg in adults)

Step 2: Repeat every 3 hours until:
        - Sweating stops
        - Extremities become warm
        - BP and HR normalize
        - Pulmonary edema resolves

Step 3: Total duration → usually 3-6 doses (9-18 hours)
        Monitor BP every 30 minutes after each dose

Severity-Based Approach

Prazosin + Antivenom

• Prazosin is effective as monotherapy when antivenom is unavailable
• Prazosin + antivenom gives the best outcomes - prazosin is effective especially in addition to antivenom for treatment of catecholamine excess and cardiovascular compromise - Rosen's Emergency Medicine
• When antivenom IS available, it should be the primary treatment; prazosin acts as an adjunct and temporizing agent

Monitoring After Each Dose

• BP every 30 minutes for the first 2 hours after each dose
• Watch for "first-dose phenomenon" (sudden severe hypotension after first dose) - keep patient supine and observe
• HR, respiratory rate, urine output
• Extremity temperature and sweating (clinical markers of resolution)
• Capillary refill

Key Side Effects to Watch

Other Supportive Drugs (Adults)

Summary

Adult prazosin dose for scorpion envenomation: 500 mcg-1 mg (30 mcg/kg) orally every 3 hours, immediate-release tablet only, until autonomic storm resolves. Always monitor BP after each dose. Antivenom is the definitive treatment when available; prazosin is the pharmacological antidote when antivenom is not available.

• Rosen's Emergency Medicine - Prazosin effective for catecholamine excess in Mesobuthus tamulus stings
• Harrison's Principles of Internal Medicine 22E - Prazosin for hypertension and pulmonary edema in scorpion stings
• Dermatology 2-Volume Set 5e - Prazosin reverses autonomic storm
• Bawaskar & Bawaskar protocol - 30 mcg/kg/dose, 500 mcg-1 mg per dose
• PMC5385045 - Systematic review: prazosin 500 mcg (<20 kg) or 1 mg (>20 kg) every 3 hours